The Client: Edwards Lifesciences is the global leader in patient-focused medical innovations for structural heart disease, as well as critical care and surgical monitoring. Driven by a passion to help patients, the company collaborates with the world’s leading clinicians and researchers to address unmet healthcare needs, working to improve patient outcomes and enhance lives.
The Challenge:Edwards Lifesciences was launching a new hemodynamic monitoring device positioned to cannibalism it’s existing product line.
The Solution: CPI performed a capital equipment sales strategy review. Compiled comprehensive company and competitive profile for first phase of three phase engagement. First phase included market research, interviews with regional managers, operations executives, and sales representatives (both internal and external). Delivered multiple strategic options to management based on both empirical and soft analysis of data gathered.
The Results: As a result of CPI’s efforts, Edwards Lifescience was able to double their stock price within 2 1/2 years from about 40 to over 80.
Categories: Industry - Healthcare, Services - Go-to Market Strategy
CPI provides innovation consulting, strategic analytics and application design. We collaborate with companies to help them become and remain high performance businesses.
Founded in 1994 in Irvine, CA, CPI has enjoyed 20 years of success, and continues to grow and refine its core offerings to best serve its clients and partners. CPI is proud to serve both local and regional SMB enterprises, as well as wholly-owned subsidiaries of Private Equity firms and the Fortune 500.
Local Presence. Global Reach.
Los Angeles - (818) 600-1407
Orange County - (949) 336 – 2740
Hong Kong - +852 6995 3151